Maximus 10-K: FY2026 EPS $7.27 GAAP / $8.24 Adjusted, FY2027 Margin Guidance Set
MMS sits 21% above its 52-week low of $51.036.
Summary
Maximus closed FY2026 with adjusted EPS of $8.24 on $5.23 billion of revenue, but guided FY2027 federal margins down to 14%-15% after a VA contract modification removed about $25 million of quarterly incentive revenue.
Key Events · Earnings and Guidance · MMS
-
FY2026 Results: Margin Expansion Lifts EPS
Revenue fell 3.7% to $5,230,792 thousand, but operating margin rose to 11.7% from 9.7%, lifting net income to $392,604 thousand and diluted EPS to $7.27 from $5.51; adjusted diluted EPS was $8.24 versus $7.36.
-
VA Incentive Pause Hits FY2027 Guidance
A fourth-quarter modification to the VA medical disability exam contract paused incentive payments that previously provided approximately $25 million of revenue and profit quarterly; management assumes no incentives in FY2027 and guides U.S. Federal Services operating margin to 14%-15% and U.S. Services to about 10%.
-
Backlog Falls to $13.8 Billion
Total backlog declined to $13,761 million from $15,327 million, driven by U.S. Federal Services falling to $6,895 million from $9,780 million, partly offset by U.S. Services rising to $5,431 million from $3,916 million.
-
Cash Flow Squeezed by Collection Delays
Operating cash flow dropped to $112,392 thousand from $429,372 thousand as DSO rose to 93 days from 62; more than $330 million of past-due invoices from a single large federal customer were collected after September 30.
Analysis · MMS · Trade & Services
The annual report puts audited numbers behind the morning's headlines and, more importantly, lays out what FY2027 looks like after the Agile Defense deal. Revenue fell 3.7% to $5.23 billion, but cost cuts and technology use lifted operating margin to 11.7% from 9.7%, so net income rose to $392.6 million ($7.27 diluted) from $319.0 million. The problem is forward-looking: a VA contract modification paused incentive payments that had been worth about $25 million of revenue and profit each quarter, and management assumes none of that in FY2027, guiding U.S. Federal Services margin to 14%-15% and U.S. Services to about 10%. Backlog dropped to $13.8 billion from $15.3 billion, with the federal segment down to $6.9 billion from $9.8 billion. Cash generation was the weak spot — operating cash flow of $112.4 million versus $429.4 million a year ago as days sales outstanding stretched to 93 from 62, though over $330 million of past-due federal invoices were collected after year-end. Leverage sits at 1.77x with $1.61 billion of debt, and management still plans roughly $200 million of buybacks in FY2027 while integrating the $660 million Agile Defense acquisition funded with $295 million of new term loans.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MMS was trading at $61.97 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $51.04 to $100.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.